- Home
- Publications
- Publication Search
- Publication Details
Title
Personalized therapy for breast cancer: a dream or a reality?
Authors
Keywords
-
Journal
Future Oncology
Volume 9, Issue 8, Pages 1105-1119
Publisher
Future Medicine Ltd
Online
2013-07-31
DOI
10.2217/fon.13.57
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment
- (2012) Evi S. Lianidou et al. CANCER AND METASTASIS REVIEWS
- A Missing Link in Genotype-Directed Cancer Therapy
- (2012) René Bernards CELL
- Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
- (2012) James S. Duncan et al. CELL
- The Life History of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- Characterization and Clinical Evaluation of CD10+ Stroma Cells in the Breast Cancer Microenvironment
- (2012) C. Desmedt et al. CLINICAL CANCER RESEARCH
- Drug Development: Portals of Discovery
- (2012) S. E. Bates et al. CLINICAL CANCER RESEARCH
- Phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway inhibition
- (2012) Dimitrios Zardavas et al. CURRENT OPINION IN ONCOLOGY
- The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities
- (2012) Michele De Palma et al. Molecular Oncology
- Germline pharmacogenomics in oncology: Decoding the patient for targeting therapy
- (2012) Peter H. O'Donnell et al. Molecular Oncology
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- From single cells to deep phenotypes in cancer
- (2012) Sean C Bendall et al. NATURE BIOTECHNOLOGY
- What are we learning from the cancer genome?
- (2012) Eric A. Collisson et al. Nature Reviews Clinical Oncology
- Tamoxifen and CYP2D6: A Contradiction of Data
- (2012) D. L. Hertz et al. ONCOLOGIST
- Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
- (2011) Gong Tang et al. BREAST CANCER RESEARCH AND TREATMENT
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multifactorial Approach to Predicting Resistance to Anthracyclines
- (2011) Christine Desmedt et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer
- (2011) Samir M. Hanash et al. Nature Reviews Clinical Oncology
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
- (2010) M Gerlinger et al. BRITISH JOURNAL OF CANCER
- It's Diagnostics, Stupid
- (2010) René Bernards CELL
- Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
- (2010) David J. McBride et al. GENES CHROMOSOMES & CANCER
- Germline Genetic Variation, Cancer Outcome, and Pharmacogenetics
- (2010) Linda Coate et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer
- (2010) W. Fraser Symmans et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection
- (2010) Shelly S. Lo et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors
- (2010) James N. Ingle et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer
- (2010) U. De Giorgi et al. JOURNAL OF NUCLEAR MEDICINE
- Translating cancer research into targeted therapeutics
- (2010) J. S. de Bono et al. NATURE
- Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
- (2010) Yang Li et al. NATURE MEDICINE
- Biomarkers and surrogate end points—the challenge of statistical validation
- (2010) Marc Buyse et al. Nature Reviews Clinical Oncology
- PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer
- (2010) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Profiling: Moving Away from Tumor Philately
- (2010) J. S. Reis-Filho et al. Science Translational Medicine
- Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
- (2010) R. J. Leary et al. Science Translational Medicine
- Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer
- (2009) U. De Giorgi et al. ANNALS OF ONCOLOGY
- Prognosis of BRCA-associated breast cancer: a summary of evidence
- (2009) L. Bordeleau et al. BREAST CANCER RESEARCH AND TREATMENT
- The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
- (2009) Marieke E. Straver et al. BREAST CANCER RESEARCH AND TREATMENT
- Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer
- (2009) Ugo De Giorgi et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Open innovation networks between academia and industry: an imperative for breakthrough therapies
- (2009) Teri Melese et al. NATURE MEDICINE
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer
- (2008) Elizabeth Iorns et al. CANCER CELL
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
- (2008) C. Desmedt et al. CLINICAL CANCER RESEARCH
- Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials
- (2008) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Application of the 70-Gene Profile: The MINDACT Trial
- (2008) Fatima Cardoso et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis
- (2008) Chad J. Creighton et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started